Catabasis Pharma (CATB) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CATB Hot Sheet
Join SI Premium – FREE
Catabasis Pharma (NASDAQ: CATB) reported Q3 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Tesla to launch Cybercab in Austin this month - report
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
